Cipla Rotahaler (Spiriva Handihaler)1Unit

USD $6.01

Each Cipla Rotahaler is a product applicator used with rotacaps for the taking of asthma and asthma symptoms medication in the rotacaps.

ATC Classification: R03BB04
Active Ingrediant: For use with Rotacap
Generic Name: Cipla Rotahaler
Manufacturer: Cipla Limited
Strength: 1Unit
Dosage Type: Rotahaler
Packaging Type: Box
Contains: 1 Unit

Examples of Packages sent

Medication Safety Issues

Sound-alike/look-alike issues:

Spiriva may be confused with Apidra, Inspra, Serevent

Tiotropium may be confused with ipratropium



Spiriva HandiHaler: Store at 25?C (77?F); excursions permitted between 15?C and 30?C (59?F and 86?F). Avoid extreme temperatures and moisture. Do not store capsules in HandiHaler device. Store capsules in the blister pack and only remove immediately before use. Once protective foil is peeled back and/or removed, the capsule should be used immediately; if capsule is not used immediately it should be discarded.

Spiriva Respimat: Store at 25?C (77?F); excursions are permitted between 15?C and 30?C (59?F and 86?F). Avoid freezing.


Adverse Reactions

Non-postmarketing incidences listed are for powder for inhalation unless otherwise specified.


Gastrointestinal: Xerostomia (powder and solution: 4% to 16%)

Respiratory: Upper respiratory tract infection (41% to 43%), pharyngitis (powder and solution: 7% to 16%), sinusitis (powder and solution: 3% to 11%)

1% to 10%:

Cardiovascular: Chest pain (powder and solution: ?7%), edema (dependent, 3% to 5%), angina pectoris (1% to 3%; includes exacerbation of angina pectoris), palpitations (powder and solution: ?3%), hypertension (solution: 1% to 2%)

Central nervous system: Headache (powder and solution: 4% to 6%), depression (?4%), insomnia (powder and solution: ?4%), paresthesia (1% to 3%), dizziness (powder and solution: ?3%), voice disorder (powder and solution: ?3%)

Dermatologic: Skin rash (powder and solution: 1% to 4%), pruritus (powder and solution: ?3%)

Endocrine & metabolic: Hypercholesterolemia (1% to 3%), hyperglycemia (1% to 3%)

Gastrointestinal: Abdominal pain (5% to 6%), dyspepsia (1% to 6%), constipation (powder and solution: 1% to 5%), vomiting (1% to 4%), gastrointestinal disease (not otherwise specified; 1% to 3%), gastroesophageal reflux disease (powder and solution: ?3%), oropharyngeal candidiasis (powder and solution: ?3%), stomatitis (includes ulcerative stomatitis; powder and solution: ?3%), diarrhea (solution: 1% to 2%)

Genitourinary: Urinary tract infection (powder and solution: 1% to 7%)

Hypersensitivity: Hypersensitivity reaction (powder and solution: ?3%)

Infection: Candidiasis (3% to 4%), infection (1% to 4%), herpes zoster (powder and solution: ?3%)

Neuromuscular & skeletal: Arthralgia (powder and solution: ?4%), myalgia (4%), arthritis (?3%), leg pain (1% to 3%), skeletal pain (1% to 3%)

Ophthalmic: Cataract (1% to 3%)

Respiratory: Rhinitis (powder and solution: ?6%), epistaxis (powder and solution: ?4%), cough (powder: ?3%; solution: 1% to 2% ), flu-like symptoms (?3%), bronchitis (solution: 3%), laryngitis (powder and solution: ?3%), allergic rhinitis (solution: 1% to 2%)

Miscellaneous: Fever (solution: 1% to 2%)

<1%, postmarketing, and/or case reports: Abnormal hepatic function tests, anaphylaxis, angioedema, application site irritation (powder; includes glossitis, oral mucosa ulcer, pharyngolaryngeal pain), atrial fibrillation, blurred vision, bronchospasm, dehydration, dermal ulcer, dysphagia, dysuria, gingivitis, glaucoma, glossitis, hepatic insufficiency, hoarseness, increased intraocular pressure, intestinal obstruction (includes paralytic ileus), joint swelling, limb pain, muscle spasm, mydriasis (if powder comes in contact with eyes), oropharyngeal pain, paradoxical bronchospasm, skin infection, supraventricular tachycardia, tachycardia, throat irritation, tonsillitis, urinary retention, urticaria, xeroderma

Additional information

Active Ingrediant

Generic Name

Alternate Names

, , , , , , , , , , , , , , ,


Dosage Type

Packaging Type




There are no reviews yet.

Be the first to review “Cipla Rotahaler (Spiriva Handihaler)1Unit”

Your email address will not be published. Required fields are marked *